Structure of anticancer ruthenium half-sandwich complex bound to glycogen synthase kinase 3β.
The 3.15-Å-resolution crystal structure of the R enantiomer of the highly bioactive and antiproliferative half-sandwich ruthenium complex DW12 bound to the ATP binding site of glycogen synthase kinase 3β (GSK-3β) is reported and the binding is compared with the GSK-3β binding of staurosporine and other organic inhibitors. The structure reveals a close packing of the organometallic inhibitor in the ATP binding site of GSK-3β via an induced-fit mechanism. The molecular structure of (R)-DW12 with the CO ligand oriented perpendicular to the pyridocarbazole heterocycle allows the complex to stretch the whole distance sandwiched between the faces of the N- and C-terminal lobes and to interact tightly with the flexible glycine-rich loop, which is uncommon for the interaction of GSK-3β with organic inhibitors.
Atilla-Gokcumen
G Ekin
GE
Department of Chemistry, University of Pennsylvania, 231 S. 34th Street, Philadelphia, PA 19104, USA.
Di Costanzo
Luigi
L
Meggers
Eric
E
D000970:Antineoplastic Agents / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D001665:Binding Sites / Q000187:drug effects; D018360:Crystallography, X-Ray; D004305:Dose-Response Relationship, Drug; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000302:isolation & purification; D000071679:Glycogen Synthase Kinase 3 beta; D008958:Models, Molecular; D008968:Molecular Conformation; D015394:Molecular Structure; D009942:Organometallic Compounds / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology*; D012428:Ruthenium / Q000737:chemistry*; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009942:Organometallic Compounds; D012428:Ruthenium; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3
Angew Chem Int Ed Engl. 2010 May 17;49(22):3839-42
20437440
Bioorg Med Chem Lett. 2007 May 15;17(10):2863-8
17350261
Nature. 2004 Dec 16;432(7019):824-8
15602547
J Am Chem Soc. 2008 Nov 26;130(47):15764-5
18973295
Bioorg Med Chem. 2009 Mar 1;17(5):2017-29
19200745
Angew Chem Int Ed Engl. 2006 Feb 27;45(10):1580-5
16381041
Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9
2025413
Chem Biol. 2003 Dec;10(12):1255-66
14700633
Chembiochem. 2006 Sep;7(9):1443-50
16858717
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
12393927
Cancer Res. 2007 Jan 1;67(1):209-17
17210701
Chembiochem. 2008 Dec 15;9(18):2933-6
19035373
Acta Crystallogr D Biol Crystallogr. 1993 Nov 1;49(Pt 6):588-91
15299496
J Am Chem Soc. 2006 Jan 25;128(3):877-84
16417378
ACS Chem Biol. 2008 May 16;3(5):305-16
18484710
PLoS One. 2009 Oct 20;4(10):e7112
19841674
J Med Chem. 1996 Jul 19;39(15):2887-93
8709122
Curr Opin Chem Biol. 2007 Jun;11(3):287-92
17548234
Angew Chem Int Ed Engl. 2004 Jan;43(1):46-58
14694470
J Biol Chem. 2003 Nov 14;278(46):45937-45
12928438
Chem Commun (Camb). 2009 Mar 7;(9):1001-10
19225621
J Mol Biol. 2003 Oct 17;333(2):393-407
14529625
J Org Chem. 2008 Jun 20;73(12):4443-51
18505297
J Am Chem Soc. 2004 Oct 27;126(42):13594-5
15493898
Chemistry. 2008;14(16):4816-22
18425743
Angew Chem Int Ed Engl. 2005 Mar 18;44(13):1984-7
15742314
Biochemistry. 2009 Jun 16;48(23):5187-98
19371126